Humana Exceeds Quarterly Earnings Estimates with Controlled Medical Costs
Humana reported second-quarter earnings that beat Wall Street estimates, driven by medical costs in line with expectations. The health insurer maintained its annual adjusted profit forecast despite a nearly 9% drop in premarket trading. Humana is one of the largest providers of Medicare Advantage plans and has faced pressure from rising healthcare expenses and tighter reimbursement rates over recent years. The company's quarterly medical cost ratio was reported at 91.2%, slightly above analysts' expectations of 91.19%. On an adjusted basis, it earned $7.61 per share compared to the expected $7.22. While investors have raised their expectations for insurers following improved performance from peers like UnitedHealth Group, Humana's results indicate a stable but cautious outlook in managing costs and maintaining profitability.